Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-10

Clinical Trial Update: A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near and Intermediate Vision in Pseudophakic Presbyopic Subjects [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a corneal inlay to improve near and intermediate vision in presbyopic subjects with pseudophakia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ReVision Optics, Inc. | Conditions: Presbyopia, Pseudophakia | Phase 3 | Status: UNKNOWN